Showing results (81-90 of 124) with videos related to
Sort By:
Pageof 13
Health Technology Assessment (Winchester, England)|June 6, 2026
PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine dataDavid G Lugo-Palacios, Patrick Bidulka, Paul Charlton, et al.Drug Safety|January 19, 2026
Risk of Cancer Comparing Warfarin and Direct Oral Anticoagulants: Population-Based Cohort Studies in England and Hong KongZixuan Wang, Qiuyan Yu, Julian Matthewman, et al.Vaccine|December 23, 2025
Disparities in uptake of Shingrix® vaccine in immunosuppressed individuals in England: a population-based cohort studyEleanor V H Barry, Anne M Suffel, Jemma Walker, et al.BMJ (Clinical Research Ed.)|May 8, 2024
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health dataPatrick Bidulka, David G Lugo-Palacios, Orlagh Carroll, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthJonathan Davitte, Usha Gungabissoon, Jessica Chao, et al.Pharmacoepidemiology and Drug Safety|June 27, 2015
Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepinesGema Requena, John Logie, Elisa Martin, et al.Health Technology Assessment (Winchester, England)|November 23, 2021
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weightingAlbert Prats-Uribe, Spyros Kolovos, Klara Berencsi, et al.BMC Public Health|March 12, 2021
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health recordsJemma L Walker, Daniel J Grint, Helen Strongman, et al.Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.The Lancet Regional Health. Europe|November 6, 2023
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platformBang Zheng, John Tazare, Linda Nab, et al.Pageof 13